Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Scorpio Tankers
STNG
$3.89B
| $29.9M | ﹤0.01% |
794,816
+32,680
| +4% | +$1.46M |
|
1677
Tandem Diabetes Care
TNDM
$1.38B
| $29.8M | ﹤0.01% |
1,557,210
+23,382
| +2% | +$684K |
|
|
AIV
1678
Aimco
AIV
$387M
| $29.8M | ﹤0.01% |
3,386,758
+76,275
| +2% | +$677K |
|
1679
Central Garden & Pet Co Class A
CENTA
$2.39B
| $29.8M | ﹤0.01% |
910,422
+26,973
| +3% | +$857K |
|
1680
NeoGenomics
NEO
$2.04B
| $29.7M | ﹤0.01% |
3,130,397
+97,721
| +3% | +$1.22M |
|
1681
Liberty Global Class A
LBTYA
$3.71B
| $29.7M | ﹤0.01% |
2,580,660
+347,810
| +16% | +$4.05M |
|
1682
Enact Holdings
ACT
$6.68B
| $29.4M | ﹤0.01% |
846,754
+21,726
| +3% | +$726K |
|
|
THS
1683
DELISTED
Treehouse Foods
THS
| $29.4M | ﹤0.01% |
1,085,969
+15,736
| +1% | +$499K |
|
|
RDFN
1684
DELISTED
Redfin
RDFN
| $29.3M | ﹤0.01% |
3,184,928
+105,115
| +3% | +$898K |
|
1685
Clarivate
CLVT
$1.24B
| $29.2M | ﹤0.01% |
7,427,221
+264,794
| +4% | +$1.25M |
|
1686
Pediatrix Medical
MD
$2.16B
| $29.2M | ﹤0.01% |
2,014,128
+66,332
| +3% | +$942K |
|
1687
CRA International
CRAI
$1.16B
| $29.1M | ﹤0.01% |
168,263
+6,879
| +4% | +$1.27M |
|
1688
AMERISAFE
AMSF
$564M
| $29.1M | ﹤0.01% |
554,536
+17,700
| +3% | +$897K |
|
|
SASR
1689
DELISTED
Sandy Spring Bancorp Inc
SASR
| $29.1M | ﹤0.01% |
1,053,531
-10,207
| -1% | -$325K |
|
1690
Klaviyo
KVYO
$5.42B
| $29M | ﹤0.01% |
956,307
+73,847
| +8% | +$2.98M |
|
1691
Vera Therapeutics
VERA
$2.31B
| $28.9M | ﹤0.01% |
1,202,809
+49,484
| +4% | +$1.59M |
|
1692
Safety Insurance
SAFT
$1.51B
| $28.9M | ﹤0.01% |
366,229
+13,478
| +4% | +$1.05M |
|
1693
Appian
APPN
$2.03B
| $28.9M | ﹤0.01% |
1,002,026
+29,823
| +3% | +$976K |
|
1694
Celldex Therapeutics
CLDX
$2.96B
| $28.9M | ﹤0.01% |
1,589,806
+54,890
| +4% | +$1.23M |
|
1695
Enovix
ENVX
$921M
| $28.8M | ﹤0.01% |
4,481,059
+116,685
| +3% | +$1.04M |
|
1696
ANI Pharmaceuticals
ANIP
$1.82B
| $28.8M | ﹤0.01% |
429,626
+627
| +0.1% | +$37.4K |
|
1697
United States Lime & Minerals
USLM
$3.21B
| $28.7M | ﹤0.01% |
324,541
+10,010
| +3% | +$1.04M |
|
1698
Immunovant
IMVT
$7.91B
| $28.6M | ﹤0.01% |
1,672,590
+157,570
| +10% | +$3.3M |
|
1699
Middlesex Water
MSEX
$1.07B
| $28.5M | ﹤0.01% |
444,127
+12,360
| +3% | +$672K |
|
1700
ACM Research
ACMR
$5.43B
| $28.4M | ﹤0.01% |
1,216,665
+31,793
| +3% | +$726K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 121 new positions and adding to 3,781 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 121 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.